GENFIT
GENFIT is a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases where there are considerable unmet medical needs, corresponding to a lack of approved treatments. Their pioneering research is based on a strong heritage, stemming from in-house knowledge and their desire to strive for excellence. Their drug discovery efforts are based on selecting specific nuclear receptors as tar... gets and utilizing rational drug design to optimize their drug candidates. This strong skill base associated to their scientific and clinical expertise, translational disease-driven approach and strong bioinformatics capabilities, have allowed us to build a solid scientific platform enabling us to discover and develop their drug candidates and diagnostic tools. Professor Bart Staels, a world-renowned expert in nuclear receptors, co-founded GENFIT and has played a key role in shaping their company’s expertise over the years. Today, he sits as chair of the Scientific Advisory Board, lending decades of experience and essential know-how, supporting their role as an innovative leader in the discovery of solutions for the metabolic field.
GENFIT
Industry:
Biopharma Biotechnology Health Care
Founded:
1999-09-01
Address:
Loos, Nord-Pas-de-Calais, France
Country:
France
Website Url:
http://www.genfit.com
Total Employee:
101+
Status:
Active
Contact:
33320164001
Total Funding:
93.69 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network
Similar Organizations
Alpha Biopharma
Alpha Biophama is a clinical stage biopharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Mereo Biopharma
Mereo is a new UK-based speciality biopharmaceutical company.
Minerva Neuroscience
Minerva Neurosciences is a clinical-stage biopharmaceutical company
Current Advisors List
Board_member
2008-05-01
Board_member
Advisor
Current Employees Featured
Jean-Christophe Marcoux Chief Strategy Officer @ GENFIT
Chief Strategy Officer
2017-01-01
Nathalie Huitorel Chief Financial Officer @ GENFIT
Chief Financial Officer
2007-01-01
Pascal Prigent Chief Executive Officer @ GENFIT
Chief Executive Officer
2019-09-01
Dean Hum Chief Scientific Officer @ GENFIT
Chief Scientific Officer
2000-01-01
Bart Staels Co-founder @ GENFIT
Co-founder
Jean-François Mouney President Chairman of the Board Co-Founder @ GENFIT
President Chairman of the Board Co-Founder
1999-01-01
Founder
Stock Details
Investors List
Official Site Inspections
http://www.genfit.com Semrush global rank: 6.12 M Semrush visits lastest month: 1.32 K
- Host name: 107.154.238.20.ip.incapdns.net
- IP address: 107.154.238.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "GENFIT"
About - Genfit
Listing of GENFIT on the Alternext Market of Euronext Paris and transferred in 2014 onto the Euronext Market in Paris (compartment B – ISIN: FR0004163111) ... 3 National organization …See details»
Homepage - Genfit
Our Success in PBC. In June 2023, GENFIT and Ipsen announced positive topline 52-week data from the pivotal Phase 3 trial ELATIVE ® 2 evaluating elafibranor in Primary Biliary Cholangitis …See details»
GENFIT - Crunchbase Company Profile & Funding
Professor Bart Staels, a world-renowned expert in nuclear receptors, co-founded GENFIT and has played a key role in shaping their company’s expertise over …See details»
Genfit Company Profile | Management and Employees List
Genfit Profile and History. Genfit, founded in 1999 and headquartered in Loos Hauts-de-France, is a bio-pharmaceutical company that develops therapeutic, and diagnostic solutions to meet …See details»
GENFIT - Leadership Team - The Org
The Leadership Team at GENFIT plays a critical role in guiding the company's strategic direction, overseeing drug development initiatives, and ensuring compliance within the …See details»
Contact - Genfit
GENFIT Headquarters Parc Eurasanté885, Avenue Eugène Avinée59120 LoosFrance+33 (0)3 20 16 40 00 GENFIT Corp 45 Propect St. Suite 214CambridgeMA. Go to main navigation Go to …See details»
Investor Relations - GENFIT
Dec 31, 2024 GENFIT is a biopharmaceutical group conducting late stage clinical trials dedicated to improving the lives of patients with liver diseases with high unmet medical needs, …See details»
GENFIT Overview | SignalHire Company Profile
GENFIT is a public company that has been in the industry for 25 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the CEO is occupied by …See details»
GENFIT career: recruitment in biopharmaceutical | GENFIT
GENFIT is a pioneer in liver disease research and development with a rich history and strong scientific heritage spanning more than two decades. Its capacity to develop high potential assets, from early-stages to late development and pre …See details»
GENFIT - LinkedIn
GENFIT is a pioneer in liver disease research and development with a rich history and strong scientific heritage spanning more than two decades. Its capacity to develop high potential assets, from ...See details»
Genfit Company Profile - Office Locations, Competitors, Revenue …
Oct 29, 2024 Genfit has 5 employees across 2 locations and €28.57 m in annual revenue in FY 2023. See insights on Genfit including office locations, competitors, revenue, financials, …See details»
| GENFIT
Read more about GENFIT: Ipsen’s Iqirvo® (Elafibranor) Receives EU Approval as a First-in-Class Treatment for Primary Biliary Cholangitis following U.S. FDA Accelerated Approval GENFIT …See details»
Homepage - Genfit
C’est le premier médicament développé en interne par GENFIT à obtenir l’approbation de la FDA américaine, une étape historique pour notre entreprise. Ipsen est désormais responsable des …See details»
GENFIT - Contacts, Employees, Board Members, Advisors
Organization. GENFIT . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 6. Number of Board …See details»
Genfit S.A. (LON: 0QT6) Company Profile & Overview - Stock …
Jan 10, 2025 Genfit Company Description Genfit S.A., a late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver …See details»
Financial and extra-financial reports - GENFIT
Dec 31, 2024 GENFIT's latest financial reports & financial results. GENFIT Headquarters Parc Eurasanté 885, Avenue Eugène Avinée 59120 Loos France GENFIT Corp 45 Propect St. …See details»
Therapeutic Areas - Genfit
GENFIT is a company that specializes in the discovery and development of drugs that target rare and life-threatening liver diseases with high unmet medical needs and is a world leader in …See details»
GENFIT Company Overview, Contact Details & Competitors | LeadIQ
Nov 1, 2016 GENFIT Reports Third Quarter 2024 Financial Information. Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland); November 7, 2024 - GENFIT …See details»
GENFIT Announces Completion of Non-dilutive Royalty Financing …
Mar 20, 2025 GENFIT to use €61.66 million to repurchase 1,882,891 2025 OCEANEs after exercise by certain bondholders of their put option, reducing the nominal amount of GENFIT’s …See details»
GENFIT Announces the Preliminary Results of the Repurchase …
Feb 21, 2025 A Consent Solicitation Memorandum and a report of the Company's Chief Executive Officer to the 2025 OCEANEs holders, together with the documents required by …See details»